Literature DB >> 7595881

Abnormal illness attitudes in patients with irritable bowel syndrome.

J Gomborone1, P Dewsnap, G Libby, M Farthing.   

Abstract

The Illness Attitudes Scales (IAS) and the Beck Depression Inventory (BDI) were administered to 40 patients with irritable bowel syndrome (IBS) and these were compared with 35 patients with organic gastrointestinal (GI) disease, 37 depressed patients, and 40 healthy volunteers. The BDI score was found to be greater in the IBS patients than in either the patients with organic disease or healthy subjects. All the patient groups had abnormal IAS scores compared with the healthy group, but these were most marked among the IBS patients with elevated scores on six out of the eight subscales. Three of these were specific to the IBS patients: bodily preoccupation, hypochondriacal beliefs and disease phobia. The results of this study indicate that clinical IBS is associated with abnormal illness attitudes which are not simply a reflection of either an associated depression or of experiencing physical symptoms.

Entities:  

Mesh:

Year:  1995        PMID: 7595881     DOI: 10.1016/0022-3999(94)00126-p

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  14 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  Further evidence supporting a psychological component to irritable bowel syndrome.

Authors:  M Castle; G W Libby
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

3.  Health care seeking for abdominal bloating and visible distention.

Authors:  X Jiang; G R Locke; A R Zinsmeister; C D Schleck; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2009-06-25       Impact factor: 8.171

Review 4.  Irritable bowel syndrome.

Authors:  S M Turner; J E Stewart; J J Alexopulos; J S Hill
Journal:  Curr Rev Pain       Date:  2000

Review 5.  Psychosocial determinants of irritable bowel syndrome.

Authors:  Teodora Surdea-Blaga; Adriana Băban; Dan L Dumitrascu
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

6.  Functional gastrointestinal disorders: psychological, social, and somatic features.

Authors:  E J Bennett; C Piesse; K Palmer; C A Badcock; C C Tennant; J E Kellow
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

7.  Evidence for two distinct perceptual alterations in irritable bowel syndrome.

Authors:  B D Naliboff; J Munakata; S Fullerton; R H Gracely; A Kodner; F Harraf; E A Mayer
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

8.  Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome.

Authors:  Piero Portincasa; Antonio Moschetta; Giuseppe Baldassarre; Donato F Altomare; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

9.  Different associations of health related quality of life with pain, psychological distress and coping strategies in patients with irritable bowel syndrome and inflammatory bowel disorder.

Authors:  Gabriella Seres; Zoltán Kovács; Agota Kovács; Olga Kerékgyártó; Krisztina Sárdi; Pál Demeter; Eszter Mészáros; Ferenc Túry
Journal:  J Clin Psychol Med Settings       Date:  2008-09-30

Review 10.  Melatonin for the treatment of irritable bowel syndrome.

Authors:  Kewin Tien Ho Siah; Reuben Kong Min Wong; Khek Yu Ho
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.